chiral pharmaceuticals
Recently Published Documents


TOTAL DOCUMENTS

49
(FIVE YEARS 12)

H-INDEX

21
(FIVE YEARS 3)

2020 ◽  
pp. 77-104
Author(s):  
Maria Dolores Camacho-Muñoz ◽  
Malgorzata Baranowska ◽  
Bruce Petrie

2020 ◽  
pp. 347-362
Author(s):  
Memory Zimuwandeyi ◽  
Buhlebenkosi Ndlovu ◽  
Qaphelani Ngulube ◽  
Edmond Sanganyado

2020 ◽  
pp. 249-278
Author(s):  
Christina Nannou ◽  
Dimitra Lambropoulou

2020 ◽  
Vol 394 ◽  
pp. 122589 ◽  
Author(s):  
Yuefei Ruan ◽  
Huiju Lin ◽  
Xiaohua Zhang ◽  
Rongben Wu ◽  
Kai Zhang ◽  
...  

2020 ◽  
Vol 54 (12) ◽  
pp. 7291-7301 ◽  
Author(s):  
Jonas Mechelke ◽  
Dominique Rust ◽  
Anna Jaeger ◽  
Juliane Hollender

2020 ◽  
Vol 138 ◽  
pp. 105657 ◽  
Author(s):  
Ruixue Ma ◽  
Han Qu ◽  
Bin Wang ◽  
Fang Wang ◽  
Gang Yu

Catalysts ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. 863 ◽  
Author(s):  
Qianfa Jia ◽  
Yaqiong Li ◽  
Yinhe Lin ◽  
Qiao Ren

In the last ten years, the combination of Lewis acid with N-heterocyclic carbene (NHC) catalysis has emerged as a powerful strategy in a variety of important asymmetric synthesis, due to the ready availability of starting materials, operational simplicity and mild reaction conditions. Recent findings illustrate that Lewis acid could largely enhance the efficiency and enantioselectivity, reverse the diastereoselectivity, and even influence the pathway of the same reaction partners. Herein, this review aims to reveal the recent advances in NHC-Lewis acid synergistically promoted enantioselective reactions for the expeditious assembly of versatile biologically important chiral pharmaceuticals and natural products.


Sign in / Sign up

Export Citation Format

Share Document